Responsiveness of the EQ-5D in breast cancer patients in their first year after treatment

Health and Quality of Life Outcomes

Volumn 7, Issue , 2009, Pages

  Kimman, Merel L ^a,b   Dirksen, Carmen D ^b   Lambin, Philippe ^a,b   Boersma, Liesbeth J ^a,b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EQ 5D; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; QUALITY OF LIFE; REFERENCE DATABASE; RELIABILITY; TREATMENT RESPONSE; VALIDITY; VISUAL ANALOG SCALE; BREAST TUMOR; ECONOMICS; FOLLOW UP; HEALTH CARE COST; HEALTH STATUS; QUESTIONNAIRE; VALIDATION STUDY;

BREAST NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH STATUS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES;

EID: 65349179800     PISSN: None     EISSN: 14777525     Source Type: Journal    
DOI: 10.1186/1477-7525-7-11     Document Type: Article

References (50)

1. Parkin DM Bray F Ferlay J Pisani P Global cancer statistics, 2002 CA Cancer J Clin 2005, 55:2-74. 108 10.3322/canjclin.55.2.74 15761078
2. ESMO ESMO Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of primary breast cancer Ann Oncol 2001, 12(8):1047-1048. 10.1023/A:1017448816215 11583179
3. Khatcheressian JL Wolff AC Smith TJ Grunfeld E Muss HB Vogel VG Halberg F Somerfield MR Davidson NE American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting J Clin Oncol 2006, 24(31):5091-5097. 10.1200/ JCO.2006.08.8575 17033037
4. de Bock GH Bonnema J Hage van der J Kievit J Velde van de CJ Effectiveness of routine visits and routine tests in detecting isolated locoregional recurrences after treatment for early-stage invasive breast cancer: A meta-analysis and systematic review J Clin Oncol 2004, 22(19):4010-4018. 10.1200/JCO.2004.06.080 15459225
5. Jacobs HJ van Dijck JA de Kleijn EM Kiemeney LA Verbeek AL Routine follow-up examinations in breast cancer patients have minimal impact on life expectancy: A simulation study Ann Oncol 2001, 12(8):1107-1113. 10.1023/A:1011624829512 11583192
6. te Boekhorst DS Peer NG Sluis van der RF Wobbes T Ruers TJ Periodic follow-up after breast cancer and the effect on survival Eur J Surg 2001, 167(7):490-496. 10.1080/110241501316914849 11560382
7. Allen A The meaning of the breast cancer follow-up experience for the women who attend Eur J Oncol Nurs 2002, 6(3):155-161. 10.1054/ ejon.2002.0175 12849590
8. Pennery E Mallet J A preliminary study of patients' perceptions of routine follow-up after treatment for breast cancer Eur J Oncol Nurs 2000, 4(3):138-145. discussion 146-137 10.1054/ejon.2000.0092 12849643
9. Grunfeld E Gray A Mant D Yudkin P Adewuyi-Dalton R Coyle D Cole D Stewart J Fitzpatrick R Vessey M Follow-up of breast cancer in primary care vs specialist care: Results of an economic evaluation Br J Cancer 1999, 79(7-8):1227-1233. 10.1038/sj.bjc.6690197 10098764
10. Kimman ML Voogd AC Dirksen CD Falger P Hupperets P Keymeulen K Hebly M Dehing C Lambin P Boersma LJ Improving the quality and efficiency of follow-up after curative treatment for breast cancer - rationale and study design of the MaCare trial BMC Cancer 2007, 7(1):1. 1769389 17199887 10.1186/1471-2407-7-1
11. Kimman ML Voogd AC Dirksen CD Falger P Hupperets P Keymeulen K Hebly M Dehing C Lambin P Boersma LJ Follow-up after curative treatment for breast cancer: Why do we still adhere to frequent outpatient clinic visits? Eur J Cancer 2007, 43(4):647-653. 10.1016/j.ejca.2006.12.002 17251004
12. Koinberg IL Fridlund B Engholm GB Holmberg L Nurse-led follow-up on demand or by a physician after breast cancer surgery: A randomised study Eur J Oncol Nurs 2004, 8(2):109-117. discussion 118-120 10.1016/ j.ejon.2003.12.005 15171968
13. Antoni MH Lehman JM Kilbourn KM Boyers AE Culver JL Alferi SM Yount SE McGregor BA Arena PL Harris SD Price AA Carver CS Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances benefit finding among women under treatment for early-stage breast cancer Health Psychol 2001, 20(1):20-32. 10.1037/ 0278-6133.20.1.20 11199062
14. Grunfeld E Levine MN Julian JA Coyle D Szechtman B Mirsky D Verma S Dent S Sawka C Pritchard KI Ginsburg D Wood M Whelan T Randomized trial of long-term follow-up for early-stage breast cancer: A comparison of family physician versus specialist care J Clin Oncol 2006, 24(6):848-855. 10.1200/JCO.2005.03.2235 16418496
15. Helgeson VS Cohen S Schulz R Yasko J Long-term effects of educational and peer discussion group interventions on adjustment to breast cancer Health Psychol 2001, 20(5):387-392. 10.1037/0278-6133.20.5.387 11570653
16. Marcus AC Garrett KM Cella D Wenzel LB Brady MJ Crane LA McClatchey MW Kluhsman BC Pate-Willig M Telephone counseling of breast cancer patients after treatment: A description of a randomized clinical trial Psychooncology 1998, 7(6):470-482. 10.1002/(SICI)1099-1611(199811/ 12)7:6<470::AID-PON325>3.3.CO;2-Q 9885088
17. Meneses KD McNees P Loerzel VW Su X Zhang Y Hassey LA Transition from treatment to survivorship: Effects of a psychoeducational intervention on quality of life in breast cancer survivors Oncology nursing forum 2007, 34(5):1007-1016. 10.1188/07.ONF.1007-1016 17878129
18. Sandgren AK McCaul KD Short-term effects of telephone therapy for breast cancer patients Health Psychol 2003, 22(3):310-315. 10.1037/ 0278-6133.22.3.310 12790259
19. Pickard AS Wilke CT Lin H-W Lloyd A Health utilities using the EQ-5D in studies of cancer PharmacoEconomics 2007, 25(5):365-384. 10.2165/ 00019053-200725050-00002 17488136
20. Group E EuroQol - a new facility for the measurement of health-related quality of life. The EuroQol Group Health Policy 1990, 16(3):199-208. 10.1016/0168-8510(90)90421-9 10109801
21. Drummond MF Sculpher MJ Torrance GW O'Brien BJ Stoddart GL Methods for the economic evaluation of health care programmes Oxford: Oxford University Press 3 2005.
22. Terwee CB Dekker FW Wiersinga WM Prummel MF Bossuyt PM On assessing responsiveness of health-related quality of life instruments: Guidelines for instrument evaluation Qual Life Res 2003, 12(4):349-362. 10.1023/ A:1023499322593 12797708
23. Krabbe PF Peerenboom L Langenhoff BS Ruers TJ Responsiveness of the generic EQ-5D summary measure compared to the disease-specific EORTC QLQ C-30 Qual Life Res 2004, 13(7):1247-1253. 10.1023/ B:QURE.0000037498.00754.b8 15473503
24. Eurich DT Johnson JA Reid KJ Spertus JA Assessing responsiveness of generic and specific health related quality of life measures in heart failure Health Qual Life Outcomes 2006, 4:89. 1675990 17125512 10.1186/ 1477-7525-4-89
25. Willige van de G Wiersma D Nienhuis FJ Jenner JA Changes in quality of life in chronic psychiatric patients: A comparison between EuroQol (EQ-5D) and WHOQoL Qual Life Res 2005, 14(2):441-451. 10.1007/ s11136-004-0689-y 15892433
26. Wiebe S Guyatt G Weaver B Matijevic S Sidwell C Comparative responsiveness of generic and specific quality-of-life instruments J Clin Epidemiol 2003, 56(1):52-60. 10.1016/S0895-4356(02)00537-1 12589870
27. Krahn M Bremner KE Tomlinson G Ritvo P Irvine J Naglie G Responsiveness of disease-specific and generic utility instruments in prostate cancer patients Qual Life Res 2007, 16(3):509-522. 10.1007/s11136-006-9132-x 17091359
28. Dolan P Modeling valuations for EuroQol health states Med Care 1997, 35(11):1095-1108. 10.1097/00005650-199711000-00002 9366889
29. Aaronson NK Ahmedzai S Bergman B Bullinger M Cull A Duez NJ Filiberti A Flechtner H Fleishman SB de Haes JC The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 1993, 85(5):365-376. 10.1093/jnci/85.5.365 8433390
30. Bottomley A Aaronson NK International perspective on health-related quality-of-life research in cancer clinical trials: The European Organisation for Research and Treatment of Cancer experience J Clin Oncol 2007, 25(32):5082-5086. 10.1200/JCO.2007.11.3183 17991925
31. Fayers P Bottomley A Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer Eur J Cancer 2002, 38(Suppl 4):S125-133. 10.1016/S0959-8049(01)00448-8 11858978
32. McLachlan SA Devins GM Goodwin PJ Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (QLQ-C30) as a measure of psychosocial function in breast cancer patients Eur J Cancer 1998, 34(4):10-517. 10.1016/ S0959-8049(97)10076-4 9713301
33. Osoba D Zee B Pater J Warr D Kaizer L Latreille J Psychometric properties and responsiveness of the EORTC quality of Life Questionnaire (QLQ-C30) in patients with breast, ovarian and lung cancer Quality of life research 1994, 3(5):353-364. 10.1007/BF00451727 7841968
34. Arndt V Merx H Stegmaier C Ziegler H Brenner H Persistence of restrictions in quality of life from the first to the third year after diagnosis in women with breast cancer J Clin Oncol 2005, 23(22):4945-4953. 10.1200/JCO.2005.03.475 16051947
35. Arndt V Merx H Sturmer T Stegmaier C Ziegler H Brenner H Age-specific detriments to quality of life among breast cancer patients one year after diagnosis Eur J Cancer 2004, 40(5):673-680. 10.1016/ j.ejca.2003.12.007 15010067
36. Arndt V Stegmaier C Ziegler H Brenner H A population-based study of the impact of specific symptoms on quality of life in women with breast cancer 1 year after diagnosis Cancer 2006, 107(10):2496-2503. 10.1002/ cncr.22274 17048250
37. Goodwin PJ Ennis M Bordeleau LJ Pritchard KI Trudeau ME Koo J Hood N Health-related quality of life and psychosocial status in breast cancer prognosis: Analysis of multiple variables J Clin Oncol 2004, 22(20):4184-4192. 10.1200/JCO.2004.12.091 15483029
38. Helgesson O Lissner L Mansson J Bengtsson C Quality of life in cancer survivors as observed in a population study of Swedish women Scand J Prim Health Care 2007, 1-6. 17924285
39. Schou I Ekeberg O Sandvik L Hjermstad MJ Ruland CM Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population Qual Life Res 2005, 14(8):1813-1823. 10.1007/s11136-005-4344-z 16155769
40. Waldmann A Pritzkuleit R Raspe H Katalinic A The OVIS study: Health related quality of life measured by the EORTC QLQ-C30 and -BR23 in German female patients with breast cancer from Schleswig-Holstein Qual Life Res 2007, 16(5):767-776. 10.1007/s11136-006-9161-5 17286196
41. Revicki D Hays RD Cella D Sloan J Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes Journal of clinical epidemiology 2008, 61(2):102-109. 10.1016/ j.jclinepi.2007.03.012 18177782
42. Osoba D Rodrigues G Myles J Zee B Pater J Interpreting the significance of changes in health-related quality-of-life scores J Clin Oncol 1998, 16(1):139-144. 9440735
43. Husted JA Cook RJ Farewell VT Gladman DD Methods for assessing responsiveness: A critical review and recommendations J Clin Epidemiol 2000, 53(5):459-468. 10.1016/S0895-4356(99)00206-1 10812317
44. Cohen J Statistical Power Analysis for Behavioral Science Hilsdale, NJ: Lawrence Earlbaum Associates 2 1988.
45. Goodwin PJ Black JT Bordeleau LJ Ganz PA Health-related quality-of-life measurement in randomized clinical trials in breast cancer - taking stock Journal of the National Cancer Institute 2003, 95(4):263-281. 12591983
46. Montazeri A Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007 Journal of experimental & clinical cancer research 2008, 27(1):32. 10.1186/ 1756-9966-27-32
47. Brazier J Roberts J Tsuchiya A Busschbach J A comparison of the EQ-5D and SF-6D across seven patient groups Health Econ 2004, 13(9):873-884. 10.1002/hec.866 15362179
48. Janssen MF Birnie E Bonsel GJ Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods Qual Life Res 2008, 17(3):463-473. 2275305 18320352 10.1007/s11136-008-9318-5
49. Janssen MF Birnie E Haagsma JA Bonsel GJ Comparing the standard EQ-5D three-level system with a five-level version Value Health 2008, 11(2):275-284. 10.1111/j.1524-4733.2007.00230.x 18380640
50. Guyatt GH Osoba D Wu AW Wyrwich KW Norman GR Methods to explain the clinical significance of health status measures Mayo Clinic proceedings 2002, 77(4):371-383. 10.4065/77.4.371 11936935